Short interest for Fractyl Health gives investors a sense of the degree to which investors are betting on the decline of Fractyl Health's stock. Short interest data is updated every two weeks.

Fractyl Health Stock (NASDAQ:GUTS), Short Interest Report

Fractyl Health

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACOR

BCAN

CALM

CISS

EDBL

GMDA

GUTS

INTC

LGVC

MESO

MOTS

ONMD

PLAY

SINT

VIEW

VNDA

VVPR

Shares of  Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter.

Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

NKLA

NUVB

XPEV

U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday.

Intel, XPeng And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

Intraday Update

ACON

ADTX

ALLG

ASTS

AVTX

AWIN

CIFR

CLSK

CXAI

DCFC

GCTS

GOEV

GRTS

JZXN

LIFW

MSTR

MVST

ORGS

PPSI

PTPI

QDEL

SIGA

SNAX

TPET

VERV

VTSI

XTIA

YTEN

Shares of  Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Fractyl Health Inc

WIIM

NOTE

FiscalNote Holdings shares are trading higher after the company reported better-than-expected Q1 financial results.

Wedbush analyst Alicia Reese maintains AMC Enter Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) with a Neutral and lowers the price target from $4 to $3.5.

Price Target

Analyst Ratings

Wedbush Maintains Neutral on AMC Enter Hldgs, Lowers Price Target to $3.5

Contracts

General

ERII

Energy Recovery Announced $15M In Contracts To Supply Its PX Pressure Exchanger Energy Recovery Devices To Seawater Reverse Osmosis Desalination Plants In India. All Orders Are Expected To Ship In 2024

Piper Sandler analyst Alexander Potter maintains ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) with a Neutral and raises the price target from $15 to $16.

ACVA

Piper Sandler Maintains Neutral on ACV Auctions, Raises Price Target to $16

Delta Apparel shares are trading lower after the company reported worse-than-expected Q2 financial results.

Vivienne Ming, co-founder and chief scientist of Dionysus Health emphasized the pervasive influence of artificial intelligence (AI) in our daily lives and advocated for a constitution to regulate its application.
What Happened: Ming highlighted in an <a href="https://www.ft.com/content/b16fab3e-7f19-49ab-9bbb-9bfeccbaf063">op-ed</a> in the Financial Times on Thursday that while AI is making critical life decisions, such as job applications, loan approvals, and university admissions, often unbeknownst to us, it often conflicts with civil rights.
Having firsthand experience with AI in recruitment, Ming notes that AI can make hiring decisions without the knowledge of candidates. She argues that this infringes on civil rights, similar to an interviewer asking inappropriate questions like political affiliation or family planning.
She also voices concerns about AI&#8217;s use in other areas, like automatically dismissing underperforming workers and filtering out applicants who might support unionization or exhibit job-hopping tendencies.
Ming delves into AI&#8217;s role in the loan application process, which she says is already challenging for most people. She cautions that dreams of home ownership or small business funding could be shattered by an algorithm designed to maximize financial returns for the lender.
In the healthcare sector, Ming alerts about the potential for bias in AI-driven diagnostic tools. She also expresses concerns about the use of algorithms in legal proceedings, arguing that they could compromise the right to a lawyer and judicial review.
See Also: <a href="https://www.benzinga.com/partner/markets/24/05/38581015/majority-of-us-social-media-users-make-influencer-inspired-online-purchases-according-to-new-izea?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Majority Of US Social Media Users Make Influencer-Inspired Online Purchases, According To New IZEA Study</a>
&#8220;AI needs a constitution — or more accurately, we need a constitution that defines access to artificial intelligence acting solely on our behalf as a civil right.&#8221;
&#8220;AI can do wonderful things. But civil rights can't exist in a world of hidden calculations. Just as with a lawyer or doctor, we must have AI that acts in our self-interest,&#8221; she said.
Why It Matters: The call for AI regulation is not new. The <a href="https://www.benzinga.com/government/24/03/37656982/eu-leads-with-historic-ai-regulation-nvidia-and-tech-peers-face-new-era-of-innovation">European Union led the way</a> by endorsing the world's first comprehensive regulatory framework for AI in March. 
In the U.S., Senate Majority Leader <a href="https://www.benzinga.com/news/24/05/38727604/chuck-schumer-offers-to-provide-ai-regulation-framework-for-healthcare-labor-rights-and-doomsday-sce">Chuck Schumer (D-N.Y.) recently announced </a>plans to introduce a legislative roadmap for AI regulation in May. 
However, concerns about <a href="https://www.benzinga.com/news/24/05/38691472/will-i-am-calls-for-balanced-ai-regulation-as-music-artists-demand-protection-from-technology-over-r">over-regulation stifling innovation</a> have been raised by figures such as musician and tech entrepreneur Will.i.am. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38660535/expert-slams-starbucks-ceos-response-to-falling-stock-performance-you-got-to-be-on-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Expert Slams Starbucks CEO&#8217;s Response To Falling Stock Performance: &#8216;You Got To Be On Drugs To Say Something Like That On National Television&#8217;</a>
Image Via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Government

Regulations

Tech

Health Startup Co-Founder Calls For 'AI Constitution' As Civil Rights 'Can't Exist In A World Of Hidden Calculations'

PIRS

Pieris Pharmaceuticals Received Nasdaq Notice Stating For Last 10 Consecutive Business Says, Closing Bid Price Was At $1 Or Greater

Additionally, the transaction provides for up to a &euro;4 million earnout payable to the seller over three years based on the achievement of specified revenue growth targets. AstroNova expects the transaction to add an additional&nbsp;$8 million&nbsp;to&nbsp;$10 million&nbsp;in revenue in this fiscal year.
MTEX NS operates an 81,000-square-foot engineering and manufacturing center and has strong distributors in Europe, the Middle East, and North and South America.

ALOT

AstroNova Acquires Portugal-Based MTEX NS, S.A. For Total Enterprise Value Of €24.3M

Canadian Tire Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CDNAF#OTC">CDNAF</a>) reported quarterly earnings of $1.02 per share. This is a 37.84 percent increase over earnings of $0.74 per share from the same period last year. The company reported $2.62 billion in sales this quarter. This is a 4.63 percent decrease over sales of $2.74 billion the same period last year.

Earnings

CDNAF

Canadian Tire Corp Q1 EPS $1.02 Up From $0.74 YoY, Sales $2.62B Down From $2.74B YoY

Needham analyst Quinn Bolton upgrades SiTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SITM#NASDAQ">SITM</a>) from Hold to Buy and announces $130 price target.

Upgrades

SITM

Needham Upgrades SiTime to Buy, Announces $130 Price Target

EMKR

EMCORE shares are trading lower after the company reported mixed Q2 financial results and issued Q3 revenue guidance below estimates.

Eledon Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 12.82 percent. This is a 54.67 percent increase over losses of $(0.75) per share from the same period last year.

Earnings Beats

ELDN

Eledon Pharma Q1 2024 GAAP EPS $(0.34) Beats $(0.39) Estimate

Guidance

Wag! Reaffirms 2024 Revenues Outlook Of $105M-$115M (Est $108.4M)

SEZL

Sezzle shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Shares of AppLovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/05/38715910/applovin-stock-jumps-on-strong-q1-earnings-the-details">first-quarter financial results</a>.
The company posted revenue of $1.058 billion, versus estimates of $974.361 million. Its earnings came in at 67 cents per share, versus expectations of 55 cents per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
AppLovin shares jumped 14.8% to $85.00 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Pop Culture Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) gained 60.3% to $2.71 in pre-market trading. Pop Culture reported revenue of $24 million for the six months ended Dec. 31, 2023, up from $12.75 million in the year-ago period.</li>
<li>Sezzle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) gained 36.1% to $60.87 in pre-market trading after reporting first-quarter results.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares rose 21.6% to $4.41 in pre-market trading. Inspire Veterinary Partners recently announced a 1-for-100 reverse stock split.</li>
<li>Nukkleus Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) rose 17.7% to $1.04 in today's pre-market trading.</li>
<li>Xiao-I Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) shares gained 14.3% to $1.44 in pre-market trading after the company reported a strategic partnership with a leading Hong Kong Insurance Company to enhance AI-driven customer service.</li>
<li>TuanChe Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TC#NASDAQ">TC</a>) jumped 13% to $2.61 in pre-market trading.</li>
<li>Treasure Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) gained 12.6% to $5.35 in pre-market trading. Treasure Global is expected to report its financial results for the third quarter of fiscal year 2024, after the closing bell on Tuesday, May 14.</li>
<li>Compass, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>) shares rose 12.5% to $3.69 in pre-market trading after posting first-quarter results.</li>
<li>Magnite, Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) shares gained 10.6% to $9.85 in pre-market trading after the company reported first-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) fell 36.7% to $0.8487 in pre-market trading. Tivic Health Systems shares jumped around 28% on Wednesday after the company announced the final results of its pilot research study on cervical vagus nerve stimulation.</li>
<li>CytomX Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) shares declined 35.6% to $2.70 in pre-market trading after the company reported first-quarter financial results and announced initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, demonstrating a favorable safety profile and confirmed anti-cancer activity.</li>
<li>Cardlytics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) shares fell 28.8% to $10.40 in pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) fell 27.2% to $0.6969 in pre-market trading after the company priced its $5.25 million public offering of 6,562,500 common shares and common warrants at a combined price of $0.80.</li>
<li>Delta Apparel, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLA#NYSE">DLA</a>) fell 23.5% to $2.15 pre-market trading following weaker-than-expected second-quarter results.</li>
<li>Bioventus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) shares fell 20% to $4.03 in pre-market trading. Bioventus recently reported better-than-expected first-quarter financial results and raised its FY24 guidance above estimates.</li>
<li>Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) shares declined 17.4% to $49.15 in pre-market trading after the company reported mixed first-quarter financial results.</li>
<li>Beyond Meat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) shares fell 13.4% to $7.11 in pre-market trading after the company reported a wider-than-expected loss for its first quarter. The company sees second-quarter revenue to be between $85 million and $90 million and full-year 2024 revenue to be between $315 million and $345 million.</li>
<li>Duolingo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) shares declined 12.4% to $213.95 in pre-market trading after the company reported first quarter financial results.</li>
<li>argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) fell 7.4% to $357.60 pre-market trading after the company reported first quarter financial results and issued a business update.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38722280/roblox-beyond-meat-and-3-stocks-to-watch-heading-into-thursday">Roblox, Beyond Meat And 3 Stocks To Watch Heading Into Thursday</a>

AIXI

ARGX

BYND

CDLX

COMP

CPOP

CTMX

DUOL

EXAS

MGNI

NUKK

ONVO

TIVC

Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Joshua Lee, a loyal Hertz customer, was reportedly charged a $277.39 fee for &#8220;refueling&#8221; <a href="https://www.benzinga.com/news/24/04/38453221/another-blow-to-tesla-hertzs-ev-disposal-plan-jumps-by-10k-as-car-rental-company-aims-for-95-gas-pow">an electric Tesla Model 3 </a>he rented from the company. Despite Lee&#8217;s protests, Hertz has refused to refund the fee.
What Happened: Lee was taken aback when he was charged an additional $277.39 after returning a rented Tesla Model 3 following a weekend trip to Los Angeles, The Drive <a href="https://www.thedrive.com/news/hertz-is-charging-tesla-model-3-renter-277-fee-for-gas-wont-back-down">reported </a>on Wednesday. 
Lee had opted and paid for the &#8220;Skip the Pump and Save Time&#8221; option when he made the reservation, which allows customers to return their rental cars without refilling the gas tank if the vehicle is powered by gas. When he questioned the charge, Hertz reportedly insisted that it was for refueling the electric Model 3, even though the vehicle doesn&#8217;t have a fuel tank to refill. 
Further, the user returned the car with 96% battery, the same percentage at which he picked it up. Even if he had returned it at a lower charge level, Lee should not have been charged more than $35 according to Hertz&#8217;s EV recharging policy.
However, a customer service administrator at Hertz refused to adjust or refund the charge, citing the signed rental agreement as proof that Lee was aware of the fuel option added to the contract, the report said. 
Hertz did not immediately respond to Benzinga&#8216;s request for comment on the matter. 
Hertz And Its Strained Relationship With EVs: Hertz is looking to remove 30,000 electric vehicles from its fleet this year, citing high repair costs as the driving factor.
As of the end of the first quarter, the company had already sold about 10,000 EVs, Hertz said, on which it incurred vehicle depreciation costs of $195 million.
"Upon completion, we anticipate that the remaining EV fleet will be better aligned with attractive demand for EVs with a priority on our rideshare business," company COO&nbsp;Justin Keppy&nbsp;said during the company&#8217;s first-quarter earnings call in April. 
For the first quarter, Hertz <a href="https://www.benzinga.com/markets/equities/24/04/38434391/struggle-for-hertz-continues-as-stock-loses-23-heres-why" target="_blank" rel="noreferrer noopener">reported</a>&nbsp;an adjusted loss of $1.28 per share, much higher than the analyst consensus estimate of a loss of 44 cents, owing to high operating costs. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:&nbsp;<a href="https://www.benzinga.com/news/24/05/38722034/teslas-head-of-product-launches-departs-after-feeling-ev-giant-took-pound-of-flesh-amid-mass-firings" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Head Of Product Launches Departs After Feeling EV Giant Took ‘Pound Of Flesh&#8217; Amid Mass Firings: ‘It&#8217;s Hard To See The Long Game&#8217;</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo: Hertz Corporation

Hertz Customer Fumes After Car-Rental Company Charges Him $277 For 'Refueling' Tesla And Refuses To Reimburse Money

Pop Culture Group shares are trading higher after the company reported a year-over-year increase in H2 2023 revenue results.

N-able management currently expects to achieve the following results for the full-year 2024:
<ul>
<li>Total revenue in the range of&nbsp;$462.0&nbsp;to&nbsp;$465.0 million, representing approximately&nbsp;10%&nbsp;year-over-year growth, or&nbsp;10%&nbsp;to&nbsp;11%&nbsp;growth on a constant currency basis.</li>
<li>Adjusted EBITDA in the range of&nbsp;$162.0&nbsp;to&nbsp;$165.0 million, representing approximately&nbsp;35%&nbsp;of total revenue.</li>
</ul>

NABL

N-Able Sees FY24 Total Revenue Of $462M-$465M Vs. $463.37M Estimate (Prior View: $460M-$465M), Representing Approximately 10% YoY Growth

BDTX

Black Diamond Therapeutics Expects Cash & Equivalents Of $115.2M As Of March-End To Be Sufficient To Fund Operations Into Q3 Of 2025

Health Care

Arecor and Medtronic Diabetes Collaborate To Develop A Novel Thermostable Insulin For Implantable Pump Delivery

Fractyl Health, Inc. (GUTS) has released an update to notify the public and investors about corporate charter and bylaws modifications. Fractyl Hea...

Fractyl Health Overhauls Governance Structure Post-IPO

There's a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Fractyl Health, Inc. (GUTS – Research Report) and Alto Neuro...

Analysts Offer Insights on NA Companies: Fractyl Health, Inc. (GUTS) and Alto Neuroscience, Inc. (ANRO)

BofA, Morgan Stanley bullish on newly public Fractyl Health

New public stock offerings – IPOs – are among the most exciting aspects of the stock markets. They are the face of the market's dynamism, and right...

Analysts Bet Big on These Beaten-Down IPO Stocks

Fractyl stock slides amid preclinical data for diabetes gene therapy

Fractyl Health, Inc. (GUTS) just unveiled an update. Fractyl Health, Inc. has announced a significant milestone with the FDA granting it Investigat...

Fractyl Health Gains FDA Nod to Investigate Revita Device

MSTR, BIOR and ARBK among pre-market losers

NVCR, SBNY and VITL are among after hour movers

Analyst Jason Gerberry from Bank of America Securities reiterated a Buy rating on Fractyl Health, Inc. (GUTS – Research Report) and keeping the pri...

Strong Growth Potential and Strategic Clinical Advances Reinforce Buy Rating for Fractyl Health, Inc.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Volatile stocks are short-term traders&rsquo; bread and butter. Making money both ways &ndash; whether the stock goes up or down &ndash; means that finding the most volatile stocks is the shortest path to fast cash opportunities for day traders and swing traders alike. However, finding volatile stocks is slightly more complex than merely seeing which companies have the most momentum on a particular day or finding those particularly affected by a bit of bad news.



Instead, a more efficient means of measuring volatility is by using a stock&rsquo;s beta as a proxy &mdash; the <a href="https://www.tradingview.com/markets/stocks-usa/market-movers-high-beta/">higher the beta</a>, the more volatile the stock is with the wider market. Each of these high-beta stocks is as volatile as it comes in today&rsquo;s already-frothy market, offering short-term profit opportunities for short-term traders.



<h2>Reddit (RDDT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/03/rddt1600-4-300x169.png" alt="Reddit (RDDT) app logo on a smartphone screen."><div>Source: Henry Franklin / Shutterstock.com</div></div>Is it surprising that controversial and recently listed Reddit (NYSE:<a href="https://investorplace.com/stock-quotes/rddt-stock-quote/">RDDT</a>) has a high beta and stands out as one of today&rsquo;s more volatile stocks? While its 9.22 beta is admittedly slightly artificially boosted due to its relative newness on the market, there&rsquo;s little doubt the stock offers short-term traders plenty of volatility to trade against.



Shorts and put option buyers already feasted on the volatile stock, as shares traded nearly 20% below their initial opening price and 36% below their post-IPO high. Now may be the time to cycle back into the company on its next leg up&mdash;assuming it doesn&rsquo;t keep melting downward.



Earlier this month, InvestorPlace writer David Moadel <a href="https://investorplace.com/2024/04/reddit-stock-insider-selling-raises-pump-and-dump-possibilities/">pointed to</a> a surge in insider selling as a major contributor to the stock&rsquo;s volatility. Significant insider sales include a $16 million payday for the company president and CEO, Steve Huffman, as well as more than 71,000 shares sold by Reddit&rsquo;s Chief Financial Officer, Andrew Vollero. There&rsquo;s a reason lock-up periods exist post-IPO for most companies, and this is it &mdash; but for short-term traders, the subsequent volatility is a godsend.



<h2>MicroCloud Hologram (HOLO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/holo1600-300x169.png" alt="concept of metaverse technology man hand holding hologram cyber digital data city landscape real estate building background. meta city landscape Cyberspace. hologram. metaverse concept. HOLO stock"><div>Source: boommaval / Shutterstock.com</div></div>Sitting at a 7.5 beta, MicroCloud Hologram (NASDAQ:<a href="https://investorplace.com/stock-quotes/holo-stock-quote/">HOLO</a>) may be a bit less extreme than RDDT, but that doesn&rsquo;t detract from its volatile stock status. Much of the company&rsquo;s extreme volatility stems from a mid-February <a href="https://www.morningstar.com/news/marketwatch/20240207865/microcloud-holograms-stock-surges-on-record-volume-but-dont-call-it-a-short-squeeze">short squeeze</a> that kicked off when the company executed a reverse split to prevent delisting. Shares surged from sub-$2 to more than $60 per share in just a few short days before crashing down to earth. HOLO trades at just $2.50 per share today, though that remains a fair bit higher than pre-squeeze levels.



This type of volatility puts short-term traders in a tough spot. Though low priced, there&rsquo;s likely a short opportunity present for those betting the company will keep trending downward. <a href="https://investorplace.com/2024/03/danger-danger-dont-be-enticed-by-holo-stocks-hollow-victory/">Far from profitable</a> and with a seemingly random series of value propositions, this is a fairly reasonable assumption to make. Of course, there&rsquo;s an inherent risk of the past repeating itself and putting short sellers&rsquo; hopes to bed. But, likewise, lightning rarely strikes twice &mdash; ask the Gamestop (NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) crew &mdash; and the conditions kicking off HOLO&rsquo;s February short squeeze are unlikely to materialize again.



<h2>Fractyl Health (GUTS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600-300x169.jpg" alt="Brown glass pill bottle on its side showing white pills inside, with other pill bottles behind it representing MACK stock."><div>Source: shutterstock.com/Champhei</div></div>Besides having one of the coolest tickers I&rsquo;ve ever seen, Fractyl Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/guts-stock-quote/">GUTS</a>) is our final volatile stock, clocking in with a beta at a comparatively mellow 6.5. Like Reddit, Fractyl is a <a href="https://www.drugdeliverybusiness.com/fractyl-health-goes-the-ipo-route/">recent IPO</a>, and shares slid rapidly post-listing. Hitting markets in early February, shares sold for $15 a pop before plummeting to less than half that value (currently trading just under $7 per share). Fractyl&rsquo;s per-share pricing is right in the sweet spot for short-term profit &mdash; plenty of downside available for shorts (compared to HOLO, for example), but priced low enough that you could easily see momentum pushing the price back into double-digit territory.



Another variable is increasing the volatile stock&rsquo;s rapid repricing prospects, though. A biotech stock, Fractyl, just secured <a href="https://finance.yahoo.com/news/fractyl-health-receives-fda-ide-100000519.html">FDA approval</a> for an obesity weight maintenance study to explore options for long-term weight control after discontinuing popular GLP-1-based drugs. Biotech is generally a volatile sector, and weight-loss drugs sent some stocks soaring (and some crashing) over the past few months. Keep an eye on Fractyl, because it may end up one of the most volatile stocks this year.



On the date of publication, Jeremy Flint held no positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. Passionate about simplifying complex market concepts, he focuses on fixed-income investing, alternative investments, economic analysis, and the oil, gas, and utilities sectors. Jeremy&rsquo;s work can also be found at <a href="https://jeremyflint.work/">www.jeremyflint.work</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/the-3-most-volatile-stocks-for-short-term-traders-april-2024/">The 3 Most Volatile Stocks for Short-Term Traders: April 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The 3 Most Volatile Stocks for Short-Term Traders: April 2024

ALHC

ANRO

ARBK

BDRX

BIOR

CERO

CZOO

GANX

GRDI

HOLO

IINN

LIXT

MCAF

NVCR

OCEA

PTLO

RDDT

SBNY

TWKS

VITL

IPOs

Press Releases

Fractyl Health Announces Pricing of Initial Public Offering

Management

Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials

Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity

Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs

Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting

Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024

Fractyl Health to Present at BofA Securities 2024 Health Care Conference

AngioDynamics

Axogen

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CVRx

Alpha Tau Medical

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fractyl Health Stock (NASDAQ:GUTS), Short Interest Report

People Also Watch